{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:12Z","timestamp":1772165772952,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571819"],"award-info":[{"award-number":["81571819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017599","name":"Major Science and Technology Projects of Zhejiang Province","doi-asserted-by":"crossref","award":["2017C03046"],"award-info":[{"award-number":["2017C03046"]}],"id":[{"id":"10.13039\/501100017599","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Numerous cytokines have been proven to participate in the pathogenesis of neovascular age-related macular degeneration (nAMD). The present study aimed to investigate the aqueous humor cytokine expression profile in nAMD patients before and after ranibizumab treatments in comparison to cataract patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective study included 20 treatment-na\u00efve nAMD eyes of 20 patients who received three consecutive monthly injections of ranibizumab. Aqueous humor samples were collected before the first (baseline), second (1\u2009month later), and third (2\u2009months later) injections. Controls were 20 age- and gender-matched cataract patients without any other ocular disease. The aqueous concentrations of 28 cytokines were measured using a multiplex bead assay. Central macular thickness (CMT) and maximum retinal thickness (MRT)-3\u2009mm were measured by spectral domain optical coherence tomography (SD-OCT). The greatest linear diameter (GLD) was measured by fundus fluorescein angiography (FA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three cytokines in aqueous humor, including angiogenin, interleukin-36\u03b2 (IL-36\u03b2), and fibroblast growth factor-acidic (FGF-\u03b1) were significantly higher in nAMD patients in comparison to cataract patients, both before and\u00a0after two consecutive monthly ranibizumab injections. Compared with the nAMD patients\u2019 basal levels, two consecutive monthly ranibizumab injections effectively reduced the aqueous concentrations of VEGF-A and placental growth factor (PlGF), as well as\u00a0the values of CMT, MRT-3\u2009mm, and GLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Angiogenin, IL-36\u03b2, and FGF-\u03b1 have higher expression levels in nAMD patients in comparison to cataract patients, both\u00a0before and\u00a0after 2\u2009months of ranibizumab therapy. These cytokines may have correlations with the pathogenesis of nAMD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-020-01684-7","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T08:02:42Z","timestamp":1603872162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Angiogenin, FGF-\u03b1, and IL-36\u03b2 have higher expression levels in aqueous humor of nAMD patients in comparison to cataract patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Kailin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yupeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"issue":"9","key":"1684_CR1","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","volume":"98","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014;98(9):1144\u201367.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"1684_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nri3459","volume":"13","author":"J Ambati","year":"2013","unstructured":"Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol. 2013;13(6):438\u201351.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1684_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.trsl.2014.04.005","volume":"164","author":"SA Balasubramanian","year":"2014","unstructured":"Balasubramanian SA, Krishna Kumar K, Baird PN. The role of proteases and inflammatory molecules in triggering neovascular age-related macular degeneration: basic science to clinical relevance. Transl Res. 2014;164(3):179\u201392.","journal-title":"Transl Res"},{"issue":"2","key":"1684_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","volume":"15","author":"RF Spaide","year":"1995","unstructured":"Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina (Philadelphia, Pa). 1995;15(2):100\u201310.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"3","key":"1684_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0039-6257(03)00030-4","volume":"48","author":"J Ambati","year":"2003","unstructured":"Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48(3):257\u201393.","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"1684_CR6","first-page":"353","volume":"58","author":"JZ Nowak","year":"2006","unstructured":"Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58(3):353\u201363.","journal-title":"Pharmacol Rep"},{"issue":"9","key":"1684_CR7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00018-016-2147-8","volume":"73","author":"A Kauppinen","year":"2016","unstructured":"Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K. Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci. 2016;73(9):1765\u201386.","journal-title":"Cell Mol Life Sci"},{"key":"1684_CR8","first-page":"Cd005139","volume":"3","author":"SD Solomon","year":"2019","unstructured":"Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2019;3:Cd005139.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1684_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ophtha.2013.08.035","volume":"121","author":"AA Chang","year":"2014","unstructured":"Chang AA, Li H, Broadhead GK, Hong T, Schlub TE, Wijeyakumar W, et al. Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration. Ophthalmology. 2014;121(1):188\u201392.","journal-title":"Ophthalmology."},{"issue":"11","key":"1684_CR10","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1097\/IAE.0000000000000236","volume":"34","author":"M Saito","year":"2014","unstructured":"Saito M, Kano M, Itagaki K, Oguchi Y, Sekiryu T. Switching to intravitreal aflibercept injection for polypoidal choroidal vasculopathy refractory to ranibizumab. Retina (Philadelphia, Pa). 2014;34(11):2192\u2013201.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"1","key":"1684_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00417-004-0950-7","volume":"243","author":"H Funatsu","year":"2005","unstructured":"Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K, et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol. 2005;243(1):3\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"1684_CR12","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1097\/IAE.0000000000000157","volume":"34","author":"T Agawa","year":"2014","unstructured":"Agawa T, Usui Y, Wakabayashi Y, Okunuki Y, Juan M, Umazume K, et al. Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection. Retina (Philadelphia, Pa). 2014;34(9):1811\u20138.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"4","key":"1684_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000478705","volume":"58","author":"R Motohashi","year":"2017","unstructured":"Motohashi R, Noma H, Yasuda K, Kotake O, Goto H, Shimura M. Dynamics of inflammatory factors in aqueous humor during Ranibizumab or Aflibercept treatment for age-related macular degeneration. Ophthalmic Res. 2017;58(4):209\u201316.","journal-title":"Ophthalmic Res"},{"issue":"1","key":"1684_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1167\/iovs.18-24387","volume":"60","author":"R Agrawal","year":"2019","unstructured":"Agrawal R, Balne PK, Wei X, Bijin VA, Lee B, Ghosh A, et al. Cytokine profiling in patients with exudative age-related macular degeneration and Polypoidal Choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2019;60(1):376\u201382.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1684_CR15","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"C Garlanda","year":"2013","unstructured":"Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013;39(6):1003\u201318.","journal-title":"Immunity."},{"issue":"9","key":"1684_CR16","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1097\/IAE.0b013e318285cd9e","volume":"33","author":"PS Muether","year":"2013","unstructured":"Muether PS, Neuhann I, Buhl C, Hermann MM, Kirchhof B, Fauser S. Intraocular growth factors and cytokines in patients with dry and neovascular age-related macular degeneration. Retina (Philadelphia, Pa). 2013;33(9):1809\u201314.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"7","key":"1684_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1745-7270.2008.00442.x","volume":"40","author":"X Gao","year":"2008","unstructured":"Gao X, Xu Z. Mechanisms of action of angiogenin. Acta Biochim Biophys Sin. 2008;40(7):619\u201324.","journal-title":"Acta Biochim Biophys Sin"},{"key":"1684_CR18","first-page":"576","volume":"17","author":"JM Skeie","year":"2011","unstructured":"Skeie JM, Zeng S, Faidley EA, Mullins RF. Angiogenin in age-related macular degeneration. Mol Vis. 2011;17:576\u201382.","journal-title":"Mol Vis"},{"issue":"1","key":"1684_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/10408360701713120","volume":"45","author":"M Zakrzewska","year":"2008","unstructured":"Zakrzewska M, Marcinkowska E, Wiedlocha A. FGF-1: from biology through engineering to potential medical applications. Crit Rev Clin Lab Sci. 2008;45(1):91\u2013135.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"20","key":"1684_CR20","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.2174\/138161207781039689","volume":"13","author":"M Rusnati","year":"2007","unstructured":"Rusnati M, Presta M. Fibroblast growth factors\/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. Curr Pharm Des. 2007;13(20):2025\u201344.","journal-title":"Curr Pharm Des"},{"issue":"37","key":"1684_CR21","doi-asserted-by":"publisher","first-page":"13379","DOI":"10.1073\/pnas.1324235111","volume":"111","author":"SS Oladipupo","year":"2014","unstructured":"Oladipupo SS, Smith C, Santeford A, Park C, Sene A, Wiley LA, et al. Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis. Proc Natl Acad Sci U S A. 2014;111(37):13379\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1684_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.oret.2017.04.004","volume":"2","author":"T Cabral","year":"2018","unstructured":"Cabral T, Lima LH, Mello LGM, Polido J, Correa EP, Oshima A, et al. Bevacizumab injection in patients with Neovascular age-related macular degeneration increases Angiogenic biomarkers. Ophthalmol Retina. 2018;2(1):31\u20137.","journal-title":"Ophthalmol Retina"},{"issue":"2 Suppl","key":"1684_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/107327480200902S05","volume":"9","author":"LS Rosen","year":"2002","unstructured":"Rosen LS. Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control. 2002;9(2 Suppl):36\u201344.","journal-title":"Cancer Control"},{"issue":"4","key":"1684_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11030-006-9027-3","volume":"10","author":"Y Yamazaki","year":"2006","unstructured":"Yamazaki Y, Morita T. Molecular and functional diversity of vascular endothelial growth factors. Mol Divers. 2006;10(4):515\u201327.","journal-title":"Mol Divers"},{"issue":"12","key":"1684_CR25","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-Angiogenic therapies. Genes Cancer. 2011;2(12):1097\u2013105.","journal-title":"Genes Cancer"},{"issue":"3","key":"1684_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1042\/CS20040370","volume":"109","author":"H Takahashi","year":"2005","unstructured":"Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (London, England : 1979). 2005;109(3):227\u201341.","journal-title":"Clin Sci (London, England : 1979)"},{"key":"1684_CR27","first-page":"281","volume":"19","author":"A Klettner","year":"2013","unstructured":"Klettner A, Westhues D, Lassen J, Bartsch S, Roider J. Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium\/choroid organ cultures: p38, nuclear factor kappaB, and the vascular endothelial growth factor receptor-2\/phosphatidylinositol 3 kinase pathway. Mol Vis. 2013;19:281\u201391.","journal-title":"Mol Vis"},{"issue":"5","key":"1684_CR28","doi-asserted-by":"publisher","first-page":"726","DOI":"10.4239\/wjd.v6.i5.726","volume":"6","author":"JJ Wang","year":"2015","unstructured":"Wang JJ, Zhu M, Le YZ. Functions of Muller cell-derived vascular endothelial growth factor in diabetic retinopathy. World J Diabetes. 2015;6(5):726\u201333.","journal-title":"World J Diabetes"},{"key":"1684_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bcp.2019.04.029","volume":"164","author":"M Campbell","year":"2019","unstructured":"Campbell M, Doyle SL. Current perspectives on established and novel therapies for pathological neovascularization in retinal disease. Biochem Pharmacol. 2019;164:321\u20135.","journal-title":"Biochem Pharmacol"},{"key":"1684_CR30","first-page":"1098","volume-title":"Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor","author":"T Sato","year":"2018","unstructured":"Sato T, Takeuchi M. Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor 2018; 8(1):1098."},{"key":"1684_CR31","doi-asserted-by":"publisher","first-page":"45081","DOI":"10.1038\/srep45081","volume":"7","author":"DS Ng","year":"2017","unstructured":"Ng DS, Yip YW, Bakthavatsalam M, Chen LJ, Ng TK, Lai TY, et al. Elevated angiopoietin 2 in aqueous of patients with neovascular age related macular degeneration correlates with disease severity at presentation. Sci Rep. 2017;7:45081.","journal-title":"Sci Rep"},{"issue":"10","key":"1684_CR32","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1167\/iovs.16-19772","volume":"57","author":"S Rezar-Dreindl","year":"2016","unstructured":"Rezar-Dreindl S, Sacu S, Eibenberger K, Pollreisz A, Buhl W, Georgopoulos M, et al. The intraocular cytokine profile and therapeutic response in persistent Neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2016;57(10):4144\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1684_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/IAE.0b013e318195cb15","volume":"29","author":"MI Roh","year":"2009","unstructured":"Roh MI, Kim HS, Song JH, Lim JB, Koh HJ, Kwon OW. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment. Retina (Philadelphia, Pa). 2009;29(4):523\u20139.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"10","key":"1684_CR34","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.ophtha.2012.07.041","volume":"119","author":"PS Muether","year":"2012","unstructured":"Muether PS, Hermann MM, Viebahn U, Kirchhof B, Fauser S. Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab. Ophthalmology. 2012;119(10):2082\u20136.","journal-title":"Ophthalmology."},{"issue":"3","key":"1684_CR35","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ajo.2005.10.012","volume":"141","author":"JP Tong","year":"2006","unstructured":"Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol. 2006;141(3):456\u201362.","journal-title":"Am J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-020-01684-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T12:05:12Z","timestamp":1604145912000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01684-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1684"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01684-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-24787\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]},"assertion":[{"value":"22 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for the collection and research of human aqueous humor was permitted by the Ethics Committee of the Second Affiliated Hospital, Zhejiang University School of Medicine (ID 2016\u2013043). All patients were treated in accordance with the Declaration of Helsinki, and written informed consents were obtained from all participants prior to their participation in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"431"}}